Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kahma Biotech is a South African biotechnology company and a core division of the Kahma Healthcare Group. The company specializes in the commercialization of advanced biotechnology products, with a strategic focus on adult vaccines and specialized pharmaceuticals for complex conditions. Through a synergistic partnership with The Biovac Institute, Kahma Biotech facilitates the distribution and access of essential therapies in the Sub-Saharan African region. Its portfolio includes treatments for multiple sclerosis, oncology, infectious diseases, and urology, positioning it as a significant player in the regional healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kahma Biotech.